- Home
- MDXG vs CLOV Comparison
MDXG vs CLOV Comparison
Compare MDXG & CLOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MDXG | CLOV |
|---|---|---|
| Founded | 2006 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.1B |
| IPO Year | 2007 | 2020 |
Fundamental Metrics
Financial Performance| Metric | MDXG | CLOV |
|---|---|---|
| Price | $3.91 | $2.05 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 3 |
| Target Price | ★ $10.00 | $2.90 |
| AVG Volume (30 Days) | 984.0K | ★ 5.4M |
| Earning Date | 04-29-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 14.29 | ★ 38.03 |
| EPS | ★ 0.32 | N/A |
| Revenue | $418,630,000.00 | ★ $1,924,308,000.00 |
| Revenue This Year | N/A | $52.59 |
| Revenue Next Year | $13.02 | $15.37 |
| P/E Ratio | $12.23 | ★ N/A |
| Revenue Growth | 19.99 | ★ 40.34 |
| 52 Week Low | $3.77 | $1.58 |
| 52 Week High | $7.99 | $3.92 |
Technical Indicators
Market Signals| Indicator | MDXG | CLOV |
|---|---|---|
| Relative Strength Index (RSI) | 34.89 | 61.54 |
| Support Level | $3.77 | $1.96 |
| Resistance Level | $7.39 | $2.81 |
| Average True Range (ATR) | 0.16 | 0.10 |
| MACD | 0.04 | 0.04 |
| Stochastic Oscillator | 29.21 | 87.83 |
Price Performance
Historical ComparisonAbout MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
About CLOV Clover Health Investments Corp.
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.